Grb2 is a cytoplasmic connexin, and studies have shown that Grb2 can prevent AD by binding to insulin receptors to improve the expression of downstream molecules of insulin signaling to prevent diabetic peripheral neuropathy and interacting with NOX4 to protect the cytoskeletal disassembly [39, 40]. Here, GRB2 is linked to Alzheimer disease.